We partner with the media to inform the public of the global human crisis.
Latest News
-
April 30, 2021
Indivior Applauds Biden Administration’s New Buprenorphine Practice Guidelines... -
April 29, 2021
Indivior Announces Q1 2021 Financial Results... -
April 28, 2021
Indivior Statement Regarding State Attorney General’s Recent Announcements Relating to SUBOXONE® (buprenorphine and naloxone) Film Settlements... -
April 22, 2021
Study Examining Impact of COVID-19 Pandemic on Opioid Use Disorder (OUD) Finds Greater Barriers to Care During Pandemic... -
April 22, 2021
Indivior Welcomes White House Announcement Prioritizing Expanded Access to Evidence-Based Treatment...
Upcoming Events
The information provided below is provisional and subject to change. Details of each event, including venue information, will be confirmed shortly before they are due to take place.
-
June 1, 2021
Jefferies Virtual Healthcare Conference Presentation >
-
July 29, 2021
H1 2021 Results Webcast >
Global Media Contacts
Email: IndiviorMediaContacts@indivior.com
Phone: +1 804-594-0836
UK Media Contacts
Tulchan Communications LLP
85 Fleet Street
London
EC4Y 1AE
Indivior@Tulchangroup.com
Phone: +44 (020) 7353 4200
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
Media Kit
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline